# Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

Study · id `cardio:ct-nct01379677` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01379677](<https://clinicaltrials.gov/study/NCT01379677>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01379677

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

## Technical summary

Registry record NCT01379677. Non-randomized; no masking; primary purpose diagnostic. Start 2011-02 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 135 participants (enrolled count; ClinicalTrials.gov record NCT01379677, source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01379677, source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01379677, source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)
- Completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01379677, source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01379677, source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01379677-2014-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
- Condition: Coronary Artery Disease
- Intervention (Drug): Rubidium-82
- Intervention (Drug): Sestamibi. reconstitution with sodium pertechnetate (99mTc)
- Lead sponsor: Advanced Accelerator Applications
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: c44d8a97721feda5e3f1bc8e76f95b8ed99ff8b347b9910c473c36b7fd565f5c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
